Efficacy of early single low dose of rituximab in prophylaxis of EBV reactivation and EBV related post-transplant lymphoproliferative disorder after allogeneic hematopoietic cell transplantation

Rituxan (rituximab) - Roche

Prevymis (letermovir) - Merck (MSD)

Fang Liu 1,2; Yecheng Li 1; Gele Tong 2; Lina Feng 2; Jing Wu 1; Yu Sun 2; Min Chen 1; Peihua Lu 2

Dec 5, 2025